Cite
Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4
MLA
Zoe Mariño, et al. Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....355524c7f18b8361c8c01970ed648157&authtype=sso&custid=ns315887.
APA
Zoe Mariño, Sonia Pascual, Álvaro Giráldez, JoséA. Cabezas, A. Albillos, José A. Carrión, Juan Manuel Pascasio, Valentín Cuervas-Mons, A. Arencibia C. Del, C. Baliellas, José Luis Montero, Xavier Forns, Martín Prieto, J.L. Calleja, Javier Crespo, Manuel L. Romero, Javier García-Samaniego, Gloria Sánchez-Antolín, Trinidad Serrano, … J.J. Sanchez-Ruano. (2016). Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4.
Chicago
Zoe Mariño, Sonia Pascual, Álvaro Giráldez, JoséA. Cabezas, A. Albillos, José A. Carrión, Juan Manuel Pascasio, et al. 2016. “Safety and Efficacy of Sofosbuvir plus Simeprevir in a Spanish Cohort of 622 Cirrhotic Patients Infected with Genotypes 1 or 4,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....355524c7f18b8361c8c01970ed648157&authtype=sso&custid=ns315887.